Culturing embryonic stem(ES) cells is very complicated, and the success is highly dependent on identifying a suitable lot of Fetal Bovine Serum(FBS). ES cell research requires the highest serum quality to prevent adverse differentiation. Traditionally, researchers had to prescreen multiple FBS lots to locate one suitable for use; an often costly and time-consuming process that took away from research efforts.

Embryoplexis the most innovative ES-cell qualified serum replacement, and is intended to provide high performance and cost-effective option for researchers.Embryoplexis an engineered blend of recombinant proteins, amino acids , lipid and growth factors, and allows researchers to focus on more important tasks by providing well-defined and consistant ES-cell qualified serum replacement already screened and tested of toxicity, colony morphology and plating efficiency.

Embyoplexprovides outstanding and consistant performance with embryonic stem cells while maintaining the cells in their valuable undifferentiated state.Embryoplexcan minimize FBS lot-to-lot variation which is very critical to maintain, expansion and assay of stem cell.